Neural Stem Cell Transplantation for Neurodegenerative Conditions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating neurodegenerative conditions using neural stem cell transplantation face challenges such as low cell survival rates, limited neuronal differentiation, and the need for widespread grafting due to the disseminated nature of these diseases, which complicates effective treatment and regulatory approval.
Innovation Solution
The method involves isolating, expanding, and transplanting neural stem cells or progenitors from the central nervous system, which can differentiate into GABA-producing and glycine-producing neurons, and express trophic molecules to integrate into the neuronal infrastructure, thereby ameliorating neurodegenerative conditions by promoting neuronal survival and function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If neural stem cells are transplanted to treat neurodegenerative conditions, then neuronal replacement and function restoration are achieved, but cell survival rates remain low
Solution Approach 1:
The patent applies preliminary action by pre-conditioning neural stem cells through specific culture methods before transplantation. The cells are cultured in defined media with neurotrophic factors and subjected to hypoxic pre-conditioning to enhance their survival capabilities prior to implantation, thereby improving post-transplantation survival rates without compromising treatment effectiveness
Solution Approach 2:
The patent uses intermediary substances including neurotrophic factors (BDNF, GDNF, NGF), growth factors (EGF, FGF), and extracellular matrix components as mediators to support cell survival. These intermediaries are provided in the culture media and at the transplantation site to create a supportive environment that enhances cell viability and integration
2Quantity of substance
If neural stem cells are expanded in vitro, then sufficient cell numbers for widespread grafting are obtained, but neuronal differentiation capacity is limited
Solution Approach 1:
The patent applies dynamics by implementing dynamic culture conditions that can be adjusted during the expansion process. The culture media composition, oxygen tension, and growth factor concentrations are dynamically modified to first promote proliferation and then induce differentiation, allowing the cell population to transition from quantity accumulation to quality specialization
Solution Approach 2:
The patent utilizes parameter changes by systematically varying culture conditions including oxygen levels (hyperoxic vs. hypoxic conditions), growth factor concentrations, and media composition to control cell fate. These parameter changes enable the same cell population to be directed toward either proliferation or differentiation based on therapeutic requirements
3Area of stationary object
If widespread grafting is performed to address disseminated neurodegenerative diseases, then comprehensive coverage is achieved, but procedural complexity and regulatory hurdles increase
Solution Approach 1:
The patent applies universality by developing a standardized neural stem cell product that can be used for multiple neurodegenerative conditions through a single transplantation procedure. The universal cell therapy protocol can address different disease manifestations (spasticity, weakness, sensory loss) simultaneously, reducing the need for multiple specialized procedures and simplifying regulatory approval
Data Source
AI summary
A method of treating neurodegenerative conditions is provided. Neural stem cells may be implanted at and/or remote from a region of neuron degeneration. The methods can include isolating neural stem cells from regions where specific types of neurons corresponding to the neurons to be replaced are generated. The methods can include isolating neural stem cells secreting growth factors affecting the growth and/or regeneration of specific types of neuron. In this invention, we disclose a method of treating such disorders, including several neurodegenerative disorders arising from the lack of cells that produce particular neurotransmitters in neural circuitry by transplanting exogenously cultured and expanded neural progenitors which, upon transplantation into a neural tissue, differentiate into neurons capable of integrating and producing neurotransmitters in sufficient quantities and in a sufficient manner to overcome the symptoms associated with the neurodegeneration.